Sen-Ei Shai1,2,3, Yi-Ling Lai1, Brian J Huang4,5, Kai-Jen Yu6, Chi-Wei Hsieh6, Yu-Shin Chen6, Shih-Chieh Hung2,4,5. 1. Department of Thoracic Surgery, Taichung Veterans General Hospital Taichung, Taiwan. 2. Institute of Clinical Medicine, National Yang-Ming University Taipei, Taiwan. 3. National Chi Nan University Nantou, Taiwan. 4. Institute of New Drug Development, China Medical University Taichung, Taiwan. 5. Integrative Stem Cell Center, China Medical University Hospital Taichung, Taiwan. 6. Mathematical Gifted Class, Taichung Municipal First Senior High School Taichung, Taiwan.
Abstract
BACKGROUND: There remains a scarcity of both autografts and allografts for tracheal transplantation after long-segmental resection. Subsequently, tissue engineering has become a promising alternative for tracheal transplantation, which requires successful in vitro chondrogenesis. METHODS: To optimize the protocol for in situ chondrogenesis using the pig-derived whole Umbilical Cord (UC) as the starting material, it must be performed without using the UC-multipotent stromal cell (MSCs) isolation procedure. Nevertheless, chondrogenic induction is performed under a variety of conditions; with or without TGF-β1 at different concentrations, and also in combination with either a rotatory or hollow organ bioreactor. The engineered explant sections were analyzed using various histochemical and immunohistochemical stains to assess the expression of chondrocyte markers. Cell viability was determined through use of the APO-BrdU TUNEL assay kit. RESULTS: The results showed that culture conditions induced heterogeneous chondrogenesis in various compartments of the UC. Moreover, explants cultured with 10 ng/ml TGF-β1 under hypoxic (1% O2) in combination with a bioreactor, significantly enhanced the expression of aggrecan and type II collagen, but were lacking in the production of Glycosaminoglycans (GAGs), as evidenced by alcian blue staining. We speculated that whole segment UCs allowed for the differentiation into premature chondrocytes in our tissue-engineered environments. CONCLUSION: This study has provided exciting preliminary evidence showing that a stem cell-rich UC wrapped around an anatomical tracheal scaffold and implanted in vivo can induce nodes of new cartilage growth into a structurally functional tissue for the repairing of long-segmental tracheal stenosis. AJTR
BACKGROUND: There remains a scarcity of both autografts and allografts for tracheal transplantation after long-segmental resection. Subsequently, tissue engineering has become a promising alternative for tracheal transplantation, which requires successful in vitro chondrogenesis. METHODS: To optimize the protocol for in situ chondrogenesis using the pig-derived whole Umbilical Cord (UC) as the starting material, it must be performed without using the UC-multipotent stromal cell (MSCs) isolation procedure. Nevertheless, chondrogenic induction is performed under a variety of conditions; with or without TGF-β1 at different concentrations, and also in combination with either a rotatory or hollow organ bioreactor. The engineered explant sections were analyzed using various histochemical and immunohistochemical stains to assess the expression of chondrocyte markers. Cell viability was determined through use of the APO-BrdU TUNEL assay kit. RESULTS: The results showed that culture conditions induced heterogeneous chondrogenesis in various compartments of the UC. Moreover, explants cultured with 10 ng/ml TGF-β1 under hypoxic (1% O2) in combination with a bioreactor, significantly enhanced the expression of aggrecan and type II collagen, but were lacking in the production of Glycosaminoglycans (GAGs), as evidenced by alcian blue staining. We speculated that whole segment UCs allowed for the differentiation into premature chondrocytes in our tissue-engineered environments. CONCLUSION: This study has provided exciting preliminary evidence showing that a stem cell-rich UC wrapped around an anatomical tracheal scaffold and implanted in vivo can induce nodes of new cartilage growth into a structurally functional tissue for the repairing of long-segmental tracheal stenosis. AJTR
Authors: M Adelaide Asnaghi; Philipp Jungebluth; Manuela T Raimondi; Sally C Dickinson; Louisa E N Rees; Tetsuhiko Go; Tristan A Cogan; Amanda Dodson; Pier Paolo Parnigotto; Anthony P Hollander; Martin A Birchall; Maria Teresa Conconi; Paolo Macchiarini; Sara Mantero Journal: Biomaterials Date: 2009-08-03 Impact factor: 12.479
Authors: Alexander T Hillel; Janis M Taube; Toby C Cornish; Blanka Sharma; Marc Halushka; Edward F McCarthy; Grover M Hutchins; Jennifer H Elisseeff Journal: Cells Tissues Organs Date: 2009-06-18 Impact factor: 2.481
Authors: Michael J Chen; Jonathan P Whiteley; Colin P Please; Franziska Ehlicke; Sarah L Waters; Helen M Byrne Journal: J Tissue Eng Date: 2019-04-22 Impact factor: 7.813